Background Analysis: US FDA Advisory Committee to Hear About Research at CBER’s Division of Viral Products– JAN 14, 2016 (VRBPAC)
The US FDA has scheduled a Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting to hear updates about the research program in the Laboratory of Method Development, Division of Viral Products, in the Center for Biologics Evaluation and Research (CBER), at the FDA. The Committee will meet by teleconference on January 14, 2016, from 1 to 5 p.m., US EST.
See the SAC Tracker report